2018 annual financial data

Sutro Biopharma, Inc. 2018 Financial results

Sutro Biopharma, Inc. 2018 financial results with verified reported values.

Direct answer

Revenue was 38,419,000 USD.

Operating income was -37,223,000 USD and net income was -35,317,000 USD.
Operating cash flow was 12,683,000 USD.

Get free Sutro Biopharma, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
38,419,000 USD
Operating income
-37,223,000 USD
Net income
-35,317,000 USD
Operating cash flow
12,683,000 USD